Neon Therapeutics Overview
- Founded
-
2013

- Status
-
Acquired/Merged
- Employees
-
71

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$67M
- Investors
-
4
Neon Therapeutics General Information
Description
Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Contact Information
Website
www.neontherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- 40 Erie Street
- Suite 110
- Cambridge, MA 02139
- United States
Neon Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 06-May-2020 | $67M | 00000 | 0000 | Completed | Generating Revenue |
3. IPO | 27-Jun-2018 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
2. Early Stage VC (Series B) | 05-Dec-2017 | $106M | $161M | 00000 | Completed | Startup |
1. Early Stage VC (Series A) | 01-Oct-2015 | $55M | $55M | 0000 | Completed | Startup |
Neon Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.000 |
Neon Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted t
Drug Discovery
Cambridge, MA
71
As of 2019
00000
000
0000-00-00
000000&0
00000
Neon Therapeutics Competitors (61)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Corvus Pharmaceuticals | Formerly VC-backed | Burlingame, CA | 00 | 00000 | 000000 - 000 | 00000 |
000000 00000000000 | Corporation | Plymouth Meeting, PA | 000 | 000.00 | 00000000 | 000.00 |
000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
00000 00000000000 | Formerly VC-backed | Hayward, CA | 000 | 00000 | 000000000 | 00000 |
00 00000000 | Formerly VC-backed | Glasgow, United Kingdom | 00 | 000.00 | 000000000 | 000.00 |
Neon Therapeutics Board Members (13)
Name | Representing | Role | Since |
---|---|---|---|
Cary Pfeffer MD | Third Rock Ventures | Chairman | 000 0000 |
Robert Kamen Ph.D | Third Rock Ventures | Board Member | 000 0000 |
Robert Tepper MD | Third Rock Ventures | Board Member | 000 0000 |
Stephen Sherwin MD | Third Rock Ventures | Board Member | 000 0000 |
Neon Therapeutics Signals
Neon Therapeutics Former Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
ArrowMark Partners | Asset Manager | Minority | 000 0000 | 000000 0 | |
Casdin Capital | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Clal Biotechnology Industries | Venture Capital | Minority | 000 0000 | 000000 0 | |
Hillhouse Capital Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Nextech Invest | Venture Capital | Minority | 000 0000 | 000000 0 |